Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $998658.0.

  • KORU Medical Systems' Change in Accured Expenses rose 5405.61% to $998658.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 3797.71%. This contributed to the annual value of $2.2 million for FY2024, which is 28775.82% up from last year.
  • According to the latest figures from Q3 2025, KORU Medical Systems' Change in Accured Expenses is $998658.0, which was up 5405.61% from -$515975.0 recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' Change in Accured Expenses registered a high of $1.4 million during Q3 2022, and its lowest value of -$1.3 million during Q1 2023.
  • For the 5-year period, KORU Medical Systems' Change in Accured Expenses averaged around $105237.4, with its median value being $96236.0 (2023).
  • As far as peak fluctuations go, KORU Medical Systems' Change in Accured Expenses crashed by 134497.04% in 2022, and later surged by 57359.72% in 2024.
  • Over the past 5 years, KORU Medical Systems' Change in Accured Expenses (Quarter) stood at $447038.0 in 2021, then tumbled by 163.0% to -$281648.0 in 2022, then surged by 189.79% to $252898.0 in 2023, then surged by 347.3% to $1.1 million in 2024, then fell by 11.72% to $998658.0 in 2025.
  • Its last three reported values are $998658.0 in Q3 2025, -$515975.0 for Q2 2025, and $227316.0 during Q1 2025.